Geographic Variation in the Quality of Heart Failure Care Among U.S. Veterans

Revanth S Kosaraju1, Gregg C Fonarow2, Michael K Ong3

  • 1Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. Electronic address: https://twitter.com/revanthsk12.

JACC. Heart Failure
|August 5, 2023
PubMed

Insights

Geographic variations in heart failure with reduced ejection fraction (HFrEF) care exist. Targeted strategies are needed to improve guideline-directed medical therapies (GDMT) prescription in underserved regions.

Area of Science:

  • Cardiology
  • Health Services Research
  • Public Health

Background:

  • The prevalence of heart failure (HF) is increasing globally.
  • Guideline-directed medical therapies (GDMT) are proven to reduce adverse outcomes in patients with heart failure with reduced ejection fraction (HFrEF).
  • Geographic variations in the quality of HFrEF care are not well understood.

Purpose of the Study:

  • To evaluate national variations in the prescription of GDMT for HFrEF within the Veterans Health Administration (VHA).
  • To identify potential associations between geographic disparities in GDMT prescription and socioeconomic factors.

Main Methods:

  • A cohort of US Veterans with HFrEF was identified.
  • Patient addresses were linked to hospital referral regions (HRRs).
  • GDMT prescription data were analyzed from July 2020 to July 2021. Composite GDMT scores and prescription rates within HRRs were calculated. Geographic variation was visualized using choropleth maps, and associations with demographic factors were assessed via linear regression.

Main Results:

  • Significant geographic variation in GDMT prescription rates and composite scores was observed across HRRs.
  • Prescription rates varied by medication class, with beta-blockers being the most prescribed (80%) and angiotensin receptor-neprilysin inhibitors the least (12.2%).
  • Lower GDMT performance was associated with higher income inequality (Gini coefficient) and a greater percentage of low-income residents within HRRs.

Conclusions:

  • Substantial geographic disparities in HFrEF care quality, specifically GDMT prescription, are evident within the VHA.
  • Targeted interventions are necessary to improve GDMT uptake in lower-performing regions, particularly those facing socioeconomic challenges like poverty and income inequality.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
19
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
13
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
23
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
15
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
16